Author Correction: Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer (Nature Communications, (2023), 14, 1, (3357), 10.1038/s41467-023-38887-7)

Correction to: Nature Communications, published online 09 June 2023 This Article omits a declaration from the Competing Interests statement, which should have included the following: ‘A patent “Inhibitors of ACK1/TNK2 Tyrosine Kinase” (patent no. 9,850,216; 10,017,478 and 10,336,734) covers (R)-9b compound. NPM and KM are named as inventors. These patents have been licensed by TechnoGenesys Inc. KM and NPM are co-founders of TechnoGenesys Inc., own stocks, and serve as consultants for TechnoGenesys Inc. The other authors declare no potential conflicts of interest.’ These errors have now been corrected in either the PDF or HTML versions of the article.